INTRODUCTION
============

In animals, proper balance of energy uptake, storage, and utilization relies on coordinated communication between different tissues and organs to adjust metabolism according to organism needs. This is achieved through paracrine and endocrine signals that act at the cellular level to activate signaling pathways that mediate cell and organism adaptation. Central among these pathways is the phosphatidylinositol-3-phosphate kinase (PI3K) pathway, an evolutionarily conserved signaling cascade that adjusts metabolism according to nutrient availability ([@B8]; [@B52]). In mammals, glucose levels and metabolism are fine-tuned by insulin, which is secreted by pancreatic β-cells and delivered through the bloodstream to target tissues. Insulin binds its receptor on the plasma membrane of target tissues, activating the PI3K signaling pathway, which increases glucose uptake, storage, and utilization ([@B35]).

The insulin signaling pathway is highly conserved between mammals and *Drosophila* ([@B7]; [@B15]). In *Drosophila*, eight insulin-like peptides (dILPs 1--8), homologous to mammalian insulin, bind a single receptor, activating the canonical PI3K pathway ([@B9]; [@B26]; [@B11]; [@B20]). In the fruit fly the insulin signaling pathway not only regulates metabolism through a unique insulin receptor, but also controls tissue growth in a similar way as insulin-like growth factors (IGFs) and IGF receptors do in mammals ([@B15]). For this reason, the insulin cascade is known as the insulin/insulin-like signaling (IIS) pathway. dILP and IIS signaling is central for coupling growth and developmental programs with the nutritional status of the organism ([@B15]).

In recent years, significant information has been gained regarding the control of dILP transcription and release ([@B29]; [@B21]; [@B26]), but little is known about how dILP activity is terminated. This is an important aspect of IIS pathway regulation since, to attain a correct physiological outcome, not only is it important to have tight regulation of the initiation of the response, but it is also critical to shut down the cascade when it is no longer needed ([@B13]). Evidence for insulin degradation as a plausible mechanism for IIS down-regulation emerged with the description of the insulin-degrading enzyme (IDE), a zinc metalloprotease with the capacity to cleave a wide array of small peptides, with insulin being the substrate with highest affinity ([@B13]). Although the structure of human IDE has been resolved and its biochemical mechanism of action described in some detail, the physiological relevance of its insulin-degrading activity is unclear ([@B48]; [@B30]).

The *Drosophila melanogaster* insulin-degrading enzyme (dIDE) displays 44% amino acid identity with human IDE ([@B48]) and is capable of cleaving mammalian insulin in vitro ([@B19]; [@B14]; [@B33]). Its overexpression provokes phenotypes that are presumably related to insulin deficiency ([@B54]). The variety of genetic tools available in the fruit fly, the increasing knowledge on IIS pathway regulation, and the occurrence of structural and functional similarities with mammalian systems ([@B52]) provide an opportunity to use this model organism to define the involvement of IDE in PI3K signaling and associated pathologies.

In the present study we use the *Drosophila* system to explore the relationship between dIDE and the IIS pathway. Through a genetic approach, we analyze the ability of dIDE to regulate *Drosophila* insulin-like peptide 2 (dILP2) levels and thereby modulate metabolism and growth in a normal or a high-sugar diet. We propose that dIDE is a negative regulator of the PI3K pathway and that dIDE loss of function contributes to insulin resistance.

RESULTS
=======

dIDE is expressed ubiquitously
------------------------------

To begin investigating the function of dIDE, we analyzed the temporal and spatial expression pattern of its transcript. We extracted total RNA at different stages of the fruit fly life cycle and analyzed dIDE transcript levels by real-time PCR. We observed that dIDE mRNA levels are maximal in adult males, although dIDE expression can be detected throughout the life cycle ([Figure 1A](#F1){ref-type="fig"}). Next we compared the ex­pression of the transcript in different larval tissues, finding that the highest expression occurs in the fat body, with significant expression in other tissues as well ([Figure 1B](#F1){ref-type="fig"}). In publicly available databases on high-throughput transcriptomic analyses, those variations of dIDE expression in the life cycle and between organs have not been observed ([@B25]; [@B36]). To complete the analysis of dIDE transcriptional profile, we isolated a genomic region encompassing 2.9 kb upstream of the dIDE translation initiation site, including the dIDE putative promoter, and generated a *dide*--green fluorescent protein (GFP) reporter line. As depicted in [Figure 1, C--J](#F1){ref-type="fig"}, the reporter was strongly expressed in salivary glands ([Figure 1C](#F1){ref-type="fig"}), fat body ([Figure 1D](#F1){ref-type="fig"}), gut ([Figure 1, E--G](#F1){ref-type="fig"}), imaginal disc ([Figure 1H](#F1){ref-type="fig"}), tracheae ([Figure 1I](#F1){ref-type="fig"}), and brain ([Figure 1J](#F1){ref-type="fig"}). Taken together, these results suggest that dIDE is expressed in all *Drosophila* organs and cell types throughout the life cycle.

![dIDE gene expression pattern. (A) Temporal variation of the expression of *dide* throughout the life cycle, as determined by qRT-PCR. Error bars represent SD (three independent experiments). (B) Expression of *dide* in third-instar larval organs. mRNA levels were determined by qRT-PCR. Error bars represent SD (three independent experiments). (C--J) Expression of *dide* in third-instar larval organs, as revealed by expression of a nuclear GFP reporter under the control of the *dide* promoter; representative organs. (C) Salivary glands, (D) fat body, (E) anterior gut and proventriculus, (F) midgut, (G) hindgut, (H) wing imaginal disc, (I) tracheae, and (J) brain. Bars, 50 μm.](916fig1){#F1}

dIDE can modulate dILP levels
-----------------------------

Because insulin is the most prominent substrate of mammalian IDE, we sought to analyze whether dIDE is capable of cleaving dILPs. Available anti-dILP antibodies are not sensitive enough to detect endogenous dILPs in Western blots, but one antibody can recognize overexpressed levels of this peptide ([Figure 2A](#F2){ref-type="fig"}). We therefore performed an experiment in which dIDE and dILP2 were coexpressed ubiquitously and analyzed the levels of dILP2. dIDE was expressed throughout development in a UAS-dIDE transgenic line controlled by an actin-Gal4 driver in combination with the expression of dILP2 under direct control of a heat shock promoter. dILP2 was induced by exposing third-instar larvae to a 15-min heat shock, 4 h after which, whole-body homogenates were prepared for Western blot analysis. As shown in [Figure 2, A and B](#F2){ref-type="fig"}, dILP2 levels were significantly reduced in larvae that overexpressed dIDE. These results suggest that the metalloprotease dIDE can cleave dILP2.

![dIDE expression reduces dILP2 levels. (A) Anti-dILP2 Western blot of whole third- instar larval extracts prepared from individuals overexpressing dILP2 and coexpressing or not dIDE. Expression of dIDE provokes reduction of dILP2 levels. (B) Quantification of the Western blot. Error bars represent SEM (\**p* \< 0.05; Student\'s *t* test, *n* = 5).](916fig2){#F2}

dIDE provokes growth reduction in a cell-autonomous manner
----------------------------------------------------------

Given that dIDE is capable of reducing dILP2 levels, we sought to determine whether expression of this metalloprotease affects growth. Initially, we expressed dIDE ubiquitously through an actin-Gal4 driver and observed 12.3% reduction of pupal volume in comparison to control individuals ([Figure 3A](#F3){ref-type="fig"}). One possibility is that dIDE cleaves dILPs in the hemolymph, thereby limiting their access to target tissues. If this were the case, the effect of dIDE manipulation would be systemic rather than cell autonomous. We investigated this issue in wing discs. The adult wing is a bilayer of cells, so growth defects in the wing disc dorsal compartment give rise to a smaller dorsal wing layer that ultimately generates wings that are curved upward ([@B43]). This was exactly what we observed after expressing dIDE in this disc territory: the wings were curved upward ([Figure 3, B and C](#F3){ref-type="fig"}), indicating that dIDE can restrict growth in a cell-autonomous manner. To further analyze and quantify this effect, we expressed dIDE at the wing disc posterior compartment by using an engrailed-Gal4 driver (en-Gal4); we observed 19.1% reduction of region D of the wing at the posterior compartment ([@B5]), suggesting again that the effect of dIDE is cell autonomous ([Figure 3, D--F](#F3){ref-type="fig"}). Because insulin signaling is known to regulate organ growth by controlling both cell number and cell size, we quantified the contribution to growth reduction of each of these two parameters. To this end, we determined cell density at the posterior compartment of the wing by counting the hairs in a fixed area. The quantification revealed that IDE overexpression increases cell density by 11.2%, and therefore the cells are on average 11.2% smaller than those of control wings ([Figure 3G](#F3){ref-type="fig"}). Because cell size reduction accounts only partially for posterior compartment reduction (19.1%), we inferred that the latter originates from a combination of reduced cell size and reduced cell number. These conclusions were further confirmed by counting directly the cells after overexpression of dIDE under control of a *patched*-Gal4 driver in region C of the wing ([Figure 3D](#F3){ref-type="fig"}). Also in this case, reduction of the area occurred specifically in the wing territory that overexpressed the enzyme, and this reduction resulted from a combination of decreased cell size and decreased cell number (Supplemental Figure S1).

![dIDE provokes growth reduction in a cell-autonomous manner. (A) Pupae from individuals that express transgenic dIDE ubiquitously are significantly smaller than those of control siblings, as determined by their pupal volume (see *Materials and Methods*). Error bars represent SEM (\*\**p* \< 0.001; Student\'s *t* test; n ≥ 30 in three independent experiments). (B, C) Expression of dIDE in the dorsal compartment of the wing imaginal disc generates upwardly curved wings, indicating reduction of growth of this compartment. (D, E) Expression of dIDE at the posterior compartment of the disc provokes a reduction of the posterior half of the wing; this was estimated by measuring the area of the wing region D (indicated by the broken line in D, E). (F) Quantification of wing areas marked in D and E. Error bars represent SEM (\*\**p* \< 0.001; Student\'s *t* test; *n* ≥ 20 in three independent experiments). (G) Wing hair density at the posterior compartment of the wing. Following expression of dIDE, hair density increased, indicating that cell size was reduced. Cell size reduction accounts only partially for reduction of the area of the wing posterior compartment; compare delta values in F (19.1%) and G (11.2%). The remaining reduction of the area is due to decreased number of cells in the compartment. Error bars represent SEM (\*\**p* \< 0.001; Student\'s *t* test; *n* ≥ 20 in three independent experiments).](916fig3){#F3}

dIDE-dependent growth reduction is mediated by the PI3K pathway in a cell-autonomous manner
-------------------------------------------------------------------------------------------

Given that dILPs activate the PI3K pathway upon binding the insulin receptor (InR), we sought to investigate whether regulation of this pathway mediates the effect of dIDE. *Drosophila* phosphatase and tensin homologue on chromosome 10 (PTEN) is a phosphatidylinositol (3,4,5)-triphosphate phosphatase that negatively regulates PI3K signaling downstream of the InR ([@B22]; [@B28]), so it is expected that PTEN reduction of function will antagonize the effect of dIDE. Indeed, as depicted in [Figure 4, A--C and E](#F4){ref-type="fig"}, loss of one dose of PTEN largely suppresses dIDE-dependent growth impairment, supporting the notion that dIDEs exerts its effect by modulating PI3K pathway activation.

![Reduction of growth upon dIDE expression is mediated by the PI3K pathway. (A--D) The wing curvature provoked by the expression dIDE at the dorsal compartment of the imaginal disc (A, B) is partially suppressed in flies lacking one dose of PTEN (C) or FOXO (D). (E, F) Reduction of the area of the posterior compartment provoked by the expression of dIDE under control of an *en*-Gal4 driver (assessed by determination of the wing region D) is partially reverted in individuals lacking one dose of PTEN (E) or FOXO (F). These results (A--F) indicate that the PI3K pathway mediates dIDE-dependent growth reduction through the regulation of FOXO. Error bars represent SEM (*p* \< 0.05; one-way analysis of variance (ANOVA) with Tukey post hoc test; means with a letter in common are not significantly different; *n* ≥ 20 in three independent experiments). (G, H) The FOXO target gene *thor* is induced at the posterior compartment of the wing imaginal disc upon expression of dIDE in the same compartment, suggesting that dIDE-dependent inactivation of the PI3K pathway and activation of FOXO is cell autonomous. In *foxo^25^* (I) or *foxo^21^* (J) heterozygous mutant larvae, dIDE-dependent *thor* transcription is reduced, confirming that FOXO mediates *thor-LacZ* induction in this setting. Bar, 100 μm.](916fig4){#F4}

The PI3K pathway signals in part through *Drosophila* forkhead box, subgroup O transcription factor (FOXO). Activation of the cascade leads to phosphorylation and nuclear exclusion of FOXO, resulting in reduced FOXO-dependent transcription ([@B31]; [@B42]). To investigate whether dILP-dependent reduction of growth is mediated in part by FOXO, we took a genetic approach similar to that described for PTEN. We observed that FOXO reduction of function antagonized the effect of dIDE, as the wing curvature observed upon expression of dIDE in the dorsal compartment was partially suppressed in FOXO-heterozygous individuals ([Figure 4, A, B, and D](#F4){ref-type="fig"}), and similarly, the reduction of the wing posterior compartment observed upon *en*-Gal4 driven expression of dIDE was also suppressed in FOXO heterozygotes ([Figure 4F](#F4){ref-type="fig"}). To confirm that dIDE can increase FOXO-dependent transcription, we examined the induction of the FOXO target gene *thor* ([@B53]) by using a *thor-*LacZ enhancer trap. As depicted in [Figure 4, G and H](#F4){ref-type="fig"}, β-galactosidase expression was detected only at the posterior wing disc compartment of en-Gal4/UAS-dIDE individuals, confirming that dIDE indeed induces FOXO-dependent transcription and that the effect of dIDE is cell autonomous. Consistent with the experiments described earlier, expression of *thor*-LacZ was largely suppressed in larvae that were heterozygous for FOXO ([Figure 4, I and J](#F4){ref-type="fig"}). Taken together, these results suggest that dIDE-dependent growth reduction is mediated by a cell-autonomous mechanism that involves the negative regulation of the PI3K pathway and consequent activation of the transcription factor FOXO.

dIDE accumulates in the cytoplasm and plasma membrane of the cells in which it is expressed
-------------------------------------------------------------------------------------------

The cell-autonomous effect of dIDE suggested that the enzyme is not secreted freely to the hemolymph but instead exerts its effect locally in the cell in which it is expressed. To analyze this, we generated a transgenic line expressing a dIDE:GFP fusion protein, which was initially induced at the wing imaginal disc under control of a *ptc*-Gal4 driver. dIDE:GFP did not diffuse away from the row of *ptc*-positive cells ([Figure 5A](#F5){ref-type="fig"}). Instead, part of the fusion protein accumulated at the plasma membrane, and no protein could be detected at the lumen of the imaginal disc between the columnar epithelium and the peripodial membrane ([Figure 5, B and C](#F5){ref-type="fig"}). The expression of dIDE:GFP in the *patched* expression pattern provokes reduction of the distance between veins III and IV, which is even more pronounced than the reduction elicited by the expression of the untagged dIDE ([Figure 5, D--G](#F5){ref-type="fig"}). This indicates that dIDE:GFP is biologically active, suggesting that subcellular localization of the GFP fusion protein recapitulates the localization of endogenous dIDE. *ptc*-Gal4 drives transgene expression also in the salivary gland, so we studied subcellular localization of dIDE:GFP in this organ. In this case too, the fusion protein appeared to be retained in the cytosol and accumulated in the plasma membrane, whereas no protein appeared to be secreted to the extracellular milieu (Supplemental Figure S2, A--F). Remarkably, the size of the salivary gland expressing dIDE:GFP was autonomously reduced (Supplemental Figure S2, G and H), confirming again that the effect of dIDE is cell autonomous. Taken together, the foregoing experiments suggest that dIDE is retained in the cytoplasm and plasma membrane of the cell in which it is expressed, explaining its cell-autonomous effect on growth regulation and modulation of the PI3K pathway.

![dIDE localizes in the cytoplasm and plasma membrane of wing imaginal disc cells. Expression of a dIDE:GFP fusion protein was induced in the wing imaginal disc through a *ptc*-Gal4 driver. (A) The fusion protein can be detected only in the narrow stripe of cells (two to four cells) that expresses *patched*, without any indication that the protein can move away into neighboring cells. (B) Longitudinal and (C) transverse *z*-sections of the wing disc showing that the fusion protein accumulates in the cytoplasm and plasma membrane (arrowheads) of *ptc*-expressing cells; scale bar, 50 μm. (D--F) The expression of dIDE (E) or dIDE:GFP (F) under control of the *ptc*-Gal4 driver reduces the distance between veins III and IV (shown in D) as compared with control wings expressing GFP alone (D). (G) Quantification of the effect of dIDE or dIDE:GFP expression on the reduction of the distance between veins III and IV. The effect of dIDE:GFP (30% reduction) is stronger than that of dIDE alone (12.6% reduction). The distance between veins III and IV is indicated as *a* (green line) in D. The distance *a* was normalized to the length of vein III, indicated as *b* (red line; \*\**p* \< 0.001; one-way ANOVA with Tukey post hoc test; *n* ≥ 20 in three independent experiments).](916fig5){#F5}

Down-regulation of dIDE provokes reduction of tissue growth and sensitizes developmental timing and metabolism to high-sucrose diets
------------------------------------------------------------------------------------------------------------------------------------

Next we sought to study the effect of dIDE loss of function on growth and metabolism. We analyzed in detail a dIDE-null mutant line generated by gene targeting ([@B54]) and found that pupal volume of these mutants is significantly reduced in comparison to wild-type siblings ([Figure 6A](#F6){ref-type="fig"}). dIDE RNA interference (RNAi) is efficient in mediating reduction of dIDE transcript levels (Supplemental Figure S3), so it was used to analyze whether the growth reduction observed in the dIDE mutants is cell autonomous. Indeed, this was the case, as expression of the RNAi in the wing disc dorsal compartment provoked a clear reduction of compartment size ([Figure 6, B and C](#F6){ref-type="fig"}, and Supplemental Figure S4), which resulted in adult wings that were curved upward ([Figure 6D and E](#F6){ref-type="fig"}). Similarly, expression of dIDE RNAi at the posterior compartment of the wing disc provoked a clear (13.9%) reduction of the area of the posterior compartment of the wing in comparison to control flies ([Figure 6F](#F6){ref-type="fig"}). Taken together, the results indicate that dIDE loss of function provokes growth reduction in a cell-autonomous manner. As a next step, we investigated whether reduced activation of the PI3K pathway accounts for growth reduction also in this setting. Following an approach similar to the one utilized earlier, we expressed dIDE RNAi in the wing disc posterior compartment of larvae that were heterozygous for PTEN or FOXO mutant alleles. Area reduction of the posterior wing compartment was strongly suppressed in both PTEN (3.2%) and FOXO (3.9%) heterozygotes ([Figure 6, F and G](#F6){ref-type="fig"}), suggesting that reduction of PI3K signaling accounts for growth impairment upon dIDE silencing. To get further evidence that FOXO mediates this growth reduction, we examined whether transcript levels of the FOXO target gene *thor* increase upon expression of dIDE RNAi. Silencing of dIDE in the fat body provoked strong up-regulation of *thor* transcription, and this up-regulation was completely suppressed in PTEN-heterozygous larvae (Supplemental Figure S5). Taken together, these results indicate that dIDE silencing provokes activation of the transcription factor FOXO through the inhibition of the PI3K pathway.

![dIDE loss of function provokes reduction of growth and sensitization to a high-sugar diet. (A) dIDE^KO^ pupae are significantly smaller than those of control (WT) siblings, as assessed by calculating their pupal volume (see *Materials and Methods*). Error bars represent SEM (\*\**p* \< 0.001; Student\'s *t* test; *n* ≥ 30 in three independent experiments). (B, C) The dorsal compartment of the wing imaginal disc is autonomously reduced upon dIDE RNAi expression. Disc compartments can be visualized by the expression of Wingless (Wg, green); d, disc dorsal compartment; v, disc ventral compartment. Bar, 100 μm. (D, E) dIDE^RNAi^-dependent autonomous growth reduction of the dorsal compartment resulted in wings curved upward. (F, G) dIDE^RNAi^ expression at the posterior compartment of the wing disc provoked autonomous reduction of this compartment, as assessed by determination of the area of region D. Expression of RNAi in PTEN (F) or FOXO (G) heterozygous mutants caused strong suppression of growth impairment. Error bars represent SEM (*p* \< 0.05; one way ANOVA with Tukey post hoc test; means with a letter in common are not significantly different; *n* ≥ 20 in three independent experiments). (H) dIDE^KO^ and control larvae pupariate almost at the same time in standard culture medium. In a high-sugar culture medium, significant delay of pupariation of wild-type individuals occurred; this delay was increased in dIDE^KO^ larvae. Error bars represent SD (\*\**p* \< 0.001; two-way ANOVA with Duncan post hoc test; *n* = 60 in six independent experiments). (I) In WT adult flies, trehalose levels in hemolymph dropped significantly after 24-h starvation; in dIDE^KO^ individuals subjected to starvation, trehalose levels remained similar to those of well-fed animals. Error bars represent SEM (ns, non significant; \**p* \< 0.05; two-way ANOVA with Tukey post hoc test; *n* = 5). (J) dIDE^KO^ flies display augmented levels of the acetyl CoA carboxylase (ACC) transcript, used as an indicator of TAG metabolism. In high-sugar medium, ACC expression increased significantly in wild-type larvae, but ACC transcript levels in dIDE^KO^ individuals were even higher. Error bars represent SEM (\*\**p* \< 0.001; two-way ANOVA with Tukey post hoc test; *n* = 3).](916fig6){#F6}

Given that dIDE can negatively regulate dILP availability and growth ([Figure 2](#F2){ref-type="fig"}) and that this effect is mediated by the PI3K pathway ([Figure 4](#F4){ref-type="fig"}), the reduction of growth observed upon dIDE knockdown seems paradoxical at first glance. However, it was recently shown that *Drosophila* larvae reared in a high-sucrose diet, albeit displaying augmented levels of circulating dILPs, exhibit reduced growth and delayed developmental timing ([@B38]; [@B40]). Physiological characterization of these larvae revealed that growth impairment was due to a phenomenon known as insulin resistance ([@B38]; [@B40]). We therefore investigated whether dIDE loss of function enhances insulin resistance in *Drosophila* larvae exposed to a high-sucrose diet.

We raised wild-type individuals and larvae homozygous for the dIDE^KO^ null allele either in regular food (0.2 M sucrose) or in a high-sucrose culture medium (1 M sucrose). As depicted in [Figure 6H](#F6){ref-type="fig"}, under regular feeding conditions, wild-type and IDE^KO^ larvae developed almost at the same rate. As previously reported ([@B38]; [@B40]), in high-sucrose medium wild-type larvae exhibited a conspicuous developmental delay, pupariating 3 d later than in normal culture medium. Of interest, the delay provoked by the high-sugar diet was enhanced in dIDE^KO^ larvae, which pupariated \>1 d later than wild-type individuals ([Figure 6H](#F6){ref-type="fig"}). Similar results were obtained when reduction of dIDE levels were attained by ubiquitous expression of dIDE RNAi (Supplemental Figure S6).

In mammals, insulin resistance provokes hyperglycemia in fasting conditions, derived in part from reduced capacity of the tissues to incorporate glucose, resulting in higher-than-normal circulating sugar levels. To test whether dIDE^KO^ individuals display this metabolic phenotype, we subjected wild-type and dIDE^KO^ adult flies to 24-h starvation, after which we measured circulating levels of the disaccharide trehalose, the main circulating sugar in insects. As depicted in [Figure 6I](#F6){ref-type="fig"}, in wild-type flies trehalose levels dropped sharply after 24-h starvation, whereas in dIDE^KO^ flies, trehalose levels remained close to those observed before starvation. These results suggest that dIDE is necessary for adjusting the levels of circulating sugar levels in response to variations of the feeding conditions.

Obesity is another feature associated with insulin resistance, which originates at least in part from higher-than-normal levels of circulating triacylglycerol (TAG) and increased lipid storage. TAG levels are known to be regulated the PI3K pathway in *Drosophila* ([@B57]). It was reported that increased lipid levels correlate with augmented expression of the acetyl CoA carboxylase (ACC) gene transcript ([@B40]), the enzyme that catalyses the first step in fatty acid biosynthesis. We analyzed transcription of ACC in dIDE^KO^ and wild-type larvae reared in either regular medium or a high-sugar diet. We found that ACC transcription was strongly upregulated in IDE^KO^ flies in both regular and high-sugar food ([Figure 6J](#F6){ref-type="fig"}), suggesting that dIDE knockdown affects lipid metabolism. Taken together, the foregoing results suggest that dIDE loss of function favors the manifestation of several phenotypes that are related to insulin resistance.

DISCUSSION
==========

In this work we showed that dIDE has the capacity to modulate dILP2 levels, regulate the PI3K pathway, and affect growth. The growth phenotypes observed upon dIDE manipulation depend at least in part on the transcription factor FOXO, one of the main effectors of the PI3K pathway. Because dIDE-null mutants are homozygous viable to adulthood, dIDE is probably not a core regulator of the PI3K pathway but instead a modulator of this cascade that contributes to fine-tuning fly growth and metabolism. We showed that both dIDE gain and loss of function bring about diminished growth, results that, at first glance, seem paradoxical. Nevertheless, diminished signaling in conditions of increased insulin has been reported and is known as insulin resistance, a hallmark of human diabetes mellitus type II (DMII; [@B58]). In a DMII *Drosophila* model, larvae fed with a high-sugar diet display higher-than-normal levels of circulating dILP2, along with reduced PI3K signaling in target tissues ([@B38]; [@B40]).

The mechanisms of the genesis and progression of DMII are unclear. Although obesity, high-sugar diets, and fat-rich diets are well-established predisposition factors for the disease ([@B58]; [@B56]), genetic risk factors have also been proposed ([@B51]; [@B44]). It is noteworthy that association between IDE loss-of-function and DMII has been reported, as human populations with mutations in the IDE locus display increased incidence of this disease ([@B32]; [@B45]). In keeping with this observation, the GK rat, an animal model that recapitulates most of the features of human DMII ([@B24]), was found to carry loss-of-function mutations in the IDE locus ([@B16]; [@B18]). Experimental evidence for a role of IDE in the etiology of DMII came shortly afterward with the generation of IDE-knockout mice, which display hyperinsulinemia and glucose intolerance ([@B17]; [@B1]). Even though the mechanisms linking IDE to the genesis of DMII are elusive, a simple explanation would be that reduced degradation of insulin leads to increased insulinemia, which in turn provokes reduced insulin sensitivity due to increased receptor internalization. In this simplistic model, IDE is predicted to operate in the bloodstream, mediating insulin clearance from circulation. If this model is correct, IDE should be secreted from the cell and mediate insulin degradation extracellularly (i.e., in the bloodstream), behaving in a nonautonomous manner.

Although several studies revealed that IDE can be secreted to the extracellular milieu ([@B23]; [@B47]; [@B55]; [@B10]), other works reported the occurrence of the enzyme at other locations, such as the plasma membrane, endosomes, peroxisomes, mitochondria, and cytosol ([@B27]; [@B2]; [@B37]; [@B34]). In rat liver parenchymal cells the early endosome is a major site of degradation of insulin, although IDE was found to be cytosolic and thus is apparently not involved in endosomal degradation in this tissue ([@B41]; [@B3]; [@B12]; [@B2]).

In the present study, we found that IDE is in part associated with the plasma membrane, without any evidence of its being secreted. We provided clear evidence that its effect on growth regulation is cell autonomous, and so it is its capacity to modulate activation of the PI3K pathway. Thus, based on our genetic evidence, an attractive possibility is that dIDE is associated to plasma membrane domains that are in close proximity to insulin receptors, and so after binding of the ligand, dIDE is endocyted together with the receptor--ligand complex. Once in early endosomes, dIDE cleaves the ligand, contributing to recycling the receptor to the plasma membrane.

Of interest, it was suggested for other receptor tyrosine kinases that cleavage of the ligand at the early endosome is important for recycling the receptor to the plasma membrane ([@B49]). So, if *Drosophila* IDE does indeed exert its function at early endosomes, knockdown of dIDE is expected to cause reduction of dILP proteolysis in this compartment, leading to impairment of recycling of insulin receptors to the membrane, ultimately provoking insulin resistance. In this scenario, overexpression of dIDE may increase dILP proteolysis at the plasma membrane before ligand binding to the receptor, thereby reducing PI3K signaling. Detailed biochemical and cellular studies are required to define the precise subcellular location of dIDE and particularly the functional relevance of its possible role in early endosomes.

MATERIALS AND METHODS
=====================

Fly stocks
----------

For the generation of UAS-dIDE lines we amplified the *dide* open reading frame by PCR from the EST RE17458 (DGRC). For generation of the *dide* nGFP expression reporter we cloned a 2-kb fragment upstream of the translation initiation site with the primers 5′-GGGGTACCCCTTGGGTTTTATAAGCGTGCCAATCG-3′ and 5′-GAAGAT­CTTCAATACATGGCAATCGGTTCCAC-3′, which include sites for *Kpn*I and *Bgl*II, in a pStinger ([@B4]) nGFP vector. For the UAS-dIDE:GFP transgenic line we cloned the dIDE gene by removing the stop codon by PCR using the primers 5′-GACGAATTCATGTATCTTACGTGCAGAAAATCG-3′ and 5′-CGGGGTACCGTAAGCTTGCTGCGTGCTCCCTTCG-3′ (including sites for *Eco*RI and *Kpn*I restriction enzymes, respectively) into a pEGFP-N1 plasmid and then subcloned the fusion protein construct into a pUAST-attB plasmid ([@B6]). Transgenic lines were generated by embryo germline transformation ([@B50]).

We used the following stocks from the Bloomington *Drosophila* Stock Center (Indiana University, Bloomington, IN): *En-Gal4* (\#6356), *MS1096* (\#8696), *Ap-Gal4* (\#3041), *Act-Gal4* (\#3954, \#4414), *ptc-Gal4* (\#2017), and *thor^1^* (\#9558). The following stocks were from the Vienna *Drosophila* RNAi Center: UAS-dIDE^RNAi^ (\#15957 and \#15958) and UAS-Dcr2 (\#60009). The following stocks were obtained from different colleagues: *PTEN^2L117^* ([@B39]), *FOXO^21^* and *FOXO^25^* ([@B31]), hs-dilp2 ([@B46]), and IDE^KO^ ([@B54]). Controls for the experiments with IDE^KO^ mutants were performed in the y,w background line.

Anti-dILP2 Western blots
------------------------

First-instar larvae overexpressing or not dIDE were sorted and placed in groups of 60 individuals/vial. First, larvae were exposed to a 15-min heat shock at 37°C and then placed at 25°C for 4 h. Larvae were then recovered, rinsed in phosphate-buffered saline (PBS), and homogenized in lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 1 mM ethylene glycol tetraacetic acid, 1% NP-40, Sigma Protease Inhibitor Cocktail). After centrifugation, samples were loaded in 10% SDS--PAGE gels, run, and transferred to an Immobilon-P^SQ^ membrane (Millipore, Billerica, MA). Membranes were incubated with 1:1000 anti-dilp2 antibody (gift from Hugo Stocker, ETHZ, Zürich, Switzerland), revealed with Amersham ECL Prime (GE Healthcare, Pittsburgh, PA), and scanned. Bands were quantified using ImageJ software (National Institutes of Health, Bethesda, MD).

Immunostaining and X-Gal staining
---------------------------------

For immunostaining, larvae were dissected in PBS and fixed in PBS/Triton 0.1% (PBST) and formaldehyde 4% for 20 min at room temperature. Samples were washed with PBST and blocked with PBST bovine serum albumin 5%, followed by incubation with a primary antibody overnight at 4°C, washed, and incubated 4 h at room temperature with secondary antibodies conjugated to fluorophores. Phalloidin (1:200; Sigma, St. Louis, MO) was added during the last 30 min of secondary antibody incubation. Samples were then washed and mounted in PBST glycerol 80%. Antibodies used in this study were anti-GFP (1:1000, A-11122; Invitrogen, Carlsbad, CA) and anti-Wingless (1:1000, 4D4; Developmental Studies Hybridoma Bank, Iowa City, IA). Images were captured in a Carl Zeiss LSM510 Meta Confocal Microscope.

For X-Gal staining, larvae were dissected in PBS and fixed 10 min in a 16.67 mM KH~2~PO~4~/K~2~HPO~4~ (pH 6.8), 75 mM KCl, 25 mM NaCl, 3.33 mM MgCl~2~, 5% glutaraldehyde buffer at room temperature. Samples were then washed with PBST and incubated overnight with the staining solution (5 μM K~4~Fe(CN)~6~, 5 μM K~3~Fe(CN)~6~, 0.2%X-Gal) at room temperature. Samples were then washed and mounted for observation and photographed using an Olympus BX60 microscope equipped with an Olympus DP71 digital camera.

Quantitative real-time PCR
--------------------------

The following primers were used for quantitative real-time PCR (qRT-PCR): for dIDE, 5′-CAACGCCGCCACCTATCC-3′ and 5′-AGAGTTTACCGCATTGATTTCCC-3′; for dILP2, 5′-ATCCCGTGATTCCACACAAG-3′ and 5'-GCGGTTCCGATATCGAGTTA-3′; for ACC, 5′-GCTTGCGTGATCCCTCGTT-3′ and 5′-GATATGGGTATGCGACCAGAGAT-3′; and for Rpl29 to normalize the quantifications. qRT-PCR was performed using a Mx3005P QPCR System (Stratagene, La Jolla, CA).

Wing measurements
-----------------

First-instar larvae of the different genotypes were sorted and placed in groups of 60 individuals/vial and allowed to develop to adulthood. The 2- to 4-d-old adults were collected and conserved in 70% ethanol until analysis. The right wings of female individuals were removed and mounted in a lactic acid:ethanol (1:1) mixture. Photographs of the wings were taken with an Olympus MVX10 stereomicroscope with an Olympus DP71 digital camera. Quantification of the areas was performed with ImageJ.

Developmental timing and pupal size
-----------------------------------

First-instar larvae of the different genotypes were sorted against fluorescent balancer chromosomes and placed in groups of 60 individuals/vial and raised at 25°C. Developmental timing was assessed by counting the pupae in each vial every day at noon. Results were plotted, and curves were approximated to a Gompetz model using Infostat Statistical Software (Universidad Nacional de Córdoba, Córdoba, Argentina). The α, β, and γ parameters were calculated, and the time of 50% pupariation was determined for each repeat.

For determining pupal size, pupae were photographed at 10× magnification under an Olympus MVX10 stereomicroscope with an Olympus DP71 camera and measured using ImageJ. Pupal volume was estimated by adjusting it to the volume of a pill with hemispheric ends (*V* = π*D*^2^(3*L* − *D*)/12, where *D* is the width and *L* is the length of the pupa). Standard and high-sugar culture media were prepared as previously described ([@B40]).

Trehalose determinations
------------------------

The 2- to 4-d-old adults of each genotype were placed in vials in groups of 25 and maintained for 24 h in standard feeding conditions, after which they were transferred for fasting to 3.5-cm-diameter Petri dishes lined with a piece of Whatman No. 1 paper wet in PBS. Hemolymph was extracted from groups of 14 females by puncturing the thorax with a 0.15-gauge entomological needle and placed on a makeshift cage on the top of a 1.5-ml Eppendorf tube with a 22-nm nylon mesh. The tubes were centrifuged at 2600 × *g* for 5 min at 4°C. Hemolymph was diluted 1:20 in water and heated to 95°C for 5 min. Two microliters of sample were mixed with Fisher Hexokinase Reagent (Fisher Scientific, Pittsburgh, PA), and, after 15-min reaction, absorbance at 340 nm was recorded using a Nanodrop 1000 apparatus (Thermo Scientific, Wilmington, DE).

Statistical analysis
--------------------

Infostat Statistical Software and Excel (Microsoft, New York, NY) were used for statistical analysis where appropriate.
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dIDE

:   *Drosophila* insulin-degrading enzyme

dILP2

:   *Drosophila* insulin-like peptide 2

DMII

:   diabetes mellitus type II

FOXO

:   *Drosophila* forkhead box, subgroup O transcription factor

IDE

:   insulin-degrading enzyme

PI3K

:   phosphatidylinositol-3-phosphate kinase

PTEN

:   *Drosophila* phosphatase and tensin homologue on chromosome 10
